Shasun Pharmaceuticals, Debiopharm to manufacture Huperzine-A
As per the agreement, Shasun Pharmaceuticals will use the Debiopharm technology for the manufacture of synthetic Huperzine-A under GMP quality conditions and commercialize it in pharmaceutical and nutraceutical
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.